The Flagship Study: A 12-Week Phase Ii Study To Evaluate The Efficacy And Safety Of Aqx-1125 Following Exacerbations In Patients With Chronic Obstructive Pulmonary Disease (COPD) By Targeting The Ship1 Pathway

被引：0
|
作者：
Shrewsbury, S. B. [1 ,2 ]
Bjermer, L. [2 ]
Vestbo, J. [3 ]
Kuna, P. [4 ]
Saarelainen, P. [5 ]
Balint, B. [6 ]
Kalia, V. [1 ]
Tam, P. [1 ]
MacKenzie, L. [1 ]
机构：
[1] Aquinox Pharmaceut Inc, Richmond, BC, Canada
[2] Lund Univ, Lund, Sweden
[3] Univ Southern Denmark, Odense, Denmark
[4] Med Univ Lodz, Barlicki Univ Hosp, Lodz, Poland
[5] Univ Helsinki, Cent Hosp, Helsinki, Finland
[6] Csongrad Megyei Mellkasi Betegsegek Szakkorhaza, Deszk, Hungary
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2889
引用
收藏
页数：1
相关论文
共 38 条
  • [1] Safety And Efficacy Of Aqx-1125 In Chronic Obstructive Pulmonary Disease (COPD) - Results Of The Phase 2 Flagship Study
    Scholl, D.
    Vestbo, J.
    Tam, P.
    Mackenzie, L.
    Harwig, C.
    Toews, J.
    Shrewsbury, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [2] A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome
    Nickel, J. Curtis
    Egerdie, Blair
    Davis, Edward
    Evans, Robert
    Mackenzie, Lloyd
    Shrewsbury, Stephen B.
    JOURNAL OF UROLOGY, 2016, 196 (03): : 747 - 754
  • [3] ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients
    Rennard, Stephen I.
    Scanlon, Paul D.
    Ferguson, Gary T.
    Rekeda, Ludmyla
    Maurer, Brian T.
    Garcia Gil, Esther
    Caracta, Cynthia F.
    CLINICAL DRUG INVESTIGATION, 2013, 33 (12) : 893 - 904
  • [4] ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients
    Stephen I. Rennard
    Paul D. Scanlon
    Gary T. Ferguson
    Ludmyla Rekeda
    Brian T. Maurer
    Esther Garcia Gil
    Cynthia F. Caracta
    Clinical Drug Investigation, 2013, 33 : 893 - 904
  • [5] Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD): A qualitative exploratory study of patients' needs following discharge
    Alkhathlan, Bedor
    Greening, Neil
    Harvey-Dunstan, Theresa
    Singh, Sally
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [6] Efficacy and safety of indacaterol 150 and 300 μg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: A 12-week, placebo-controlled study
    Kinoshita, Masaharu
    Lee, Sang Haak
    Hang, Liang-Wen
    Ichinose, Masakazu
    Hosoe, Motoi
    Okino, Naoko
    Prasad, Niyati
    Kramer, Benjamin
    Fukuchi, Yoshinosuke
    RESPIROLOGY, 2012, 17 (02) : 379 - 389
  • [7] Efficacy and Safety of Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 DoseRanging Study
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Ferrucci, Silvia
    Mikol, Vincent
    Sun, Iris
    Mannent, Leda
    Gereige, Jessica
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB373 - AB373
  • [8] Combined Mometasone Furoate and Formoterol in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Phase 3 Efficacy and Safety Study
    Doherty, D. E.
    Kerwin, E.
    Tashkin, D. P.
    Matiz-Bueno, C. E.
    Shekar, T.
    Banerjee, S.
    Knorr, B.
    Staudinger, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB75 - AB75
  • [9] Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): protocol for the ICEPOC study
    Barnestein-Fonseca, Pilar
    Leiva-Fernandez, Jose
    Vidal-Espana, Francisca
    Garcia-Ruiz, Antonio
    Prados-Torres, Daniel
    Leiva-Fernandez, Francisca
    TRIALS, 2011, 12
  • [10] Safety, Efficacy, and Portrait of SARS-CoV-2 Vaccination in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Cohort Study
    Pelletier, E.
    Maltais, F.
    Desmeules, P.
    Lacasse, Y.
    Tanguay, S.
    Milot, J.
    Morissette, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
1234